{
  "retracted": false,
  "timestamp": 1550188800000,
  "updates": [
    {
      "timestamp": 1585084763759,
      "identifier": {
        "doi": "10.1158/1078-0432.ccr-18-4266"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1158/1078-0432.ccr-16-2197"
  },
  "publisher": "American Association for Cancer Research (AACR)",
  "title": "Correction: 18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials"
}
